Loading the records…
Loading the records…
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, BOBO DONALD E JR, holds the title of CVP,Strategy/Corp Development at Edwards Lifesciences Corp.
On 2026-11-09, the insider transacted 97,800 shares.The shares were transacted at a weighted average price of $87.87 per share, resulting in a total market-relevant value of $8.6M.
BOBO DONALD E JR (CVP,Strategy/Corp Development) sold $8.6M of $EW
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.